Skip to main content
The International Journal of Oncology provides an international forum for the publication of the latest, cutting-edge research in the broad area of oncology and cancer treatment. The journal accepts original high quality works and reviews on all aspects of oncology research including carcinogenesis, metastasis, epidemiology, chemotherapy and viral oncology. Through fair and efficient peer review, the journal is dedicated to publishing top tier research in the field, offering authors rapid publication as well as high standards of copy-editing and production. The International Journal of Oncology is published on a monthly basis in both print and early online.

Publisher: Spandidos Publications

More about this publication?
Volume 4, Number 2, 1 February 1994

Articles

Favourites:
ADD

ROLE OF HCG AND INHIBIN IN BREAST-CANCER (REVIEW)
pp. 297-306(10)
Authors: RUSSO, IH; RUSSO, J

Favourites:
ADD

NONRANDOM SECONDARY CHROMOSOME-ABERRATIONS IN LIPOSARCOMAS WITH T(12, 16)
pp. 307-310(4)
Authors: MANDAHL, N; MERTENS, F; AMAN, P; RYDHOLM, A; BROSJO, O; WILLEN, H; MITELMAN, F

Favourites:
ADD

EXPRESSION OF PROTEIN-KINASE-C ISOZYMES IN MULTIDRUG-RESISTANT MURINE LEUKEMIA P388/ADR CELLS
pp. 311-315(5)
Authors: GUPTA, S; KIM, C; QIN, YF; GOLLAPUDI, S

Favourites:
ADD

INTERPHASE CYTOGENETICS BY FISH ON ARCHIVAL PARAFFIN MATERIAL AND CULTURED-CELLS ON HUMAN OVARIAN-TUMORS
pp. 317-321(5)
Authors: NEUBAUER, S; LIEHR, T; TULUSAN, HA; GEBHART, E

Favourites:
ADD

TELOMERIC ASSOCIATION OF CHROMOSOMES IS AN EARLY MANIFESTATION OF PROGRAMMED CELL-DEATH
pp. 323-328(6)
Authors: PATHAK, S; RISIN, S; BROWN, NM; BERRY, K

Favourites:
ADD

SYNERGISM OF CYTOTOXICITY BETWEEN CIS-DIAMINEDICHLORO-PLATINUM-(II) AND CIS-DIAMINE(1,1-CYCLOBUTANEDICARBOXYLATE)-PLATINUM-(II)
pp. 329-333(5)
Authors: BABA, H; MAEHARA, Y; TAKEUCHI, H; INUTSUKA, S; YAMAMOTO, M; ENDO, K; SUGIMACHI, K

Favourites:
ADD

AMPLIFICATION OF SATELLITE DNA AT 16Q11.2 IN THE GERM-LINE OF A PATIENT WITH BREAST-CANCER
pp. 347-351(5)
Authors: SAVELYEVA, L; SCHNEIDER, B; FINKE, LH; SCHLAG, P; SCHWAB, M

Favourites:
ADD

MACROPHAGE INFLAMMATORY PROTEIN (MIP)-1-ALPHA STEM-CELL INHIBITOR (SCI) DOES NOT AFFECT CLONAL GROWTH OF HUMAN SOLID TUMOR-CELL LINES IN-VITRO
pp. 353-357(5)
Authors: KORFEL, A; VONMARSCHALL, Z; KOENIGSMANN, M; OBERBERG, D; REUFI, B; THIEL, E; BERDEL, WE

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

COMBINATION THERAPY OF SINGLE OR FRACTIONATED X-RAYS AND SCHIZOPHYLLAN (SPG) FOR MURINE B-16 MELANOMA
pp. 385-389(5)
Authors: TAKAI, Y; GOODMAN, GB; CHAPLIN, DJ; GRULKEY, W; LAM, GKY

Favourites:
ADD

DETECTION OF K-RAS MUTATION IN NORMAL AND MALIGNANT COLONIC TISSUES BY AN ENRICHED PCR METHOD
pp. 391-396(6)
Authors: RONAI, Z; LUO, FC; GRADIA, S; HART, WJ; BUTLER, R

Favourites:
ADD

DETECTION OF KI-RAS MUTATION IN NONNEOPLASTIC MUCOSA OF JAPANESE PATIENTS WITH COLORECTAL CANCERS
pp. 397-401(5)
Authors: MINAMOTO, T; RONAI, Z; YAMASHITA, N; OCHIAI, A; SUGIMURA, T; MAI, M; ESUMI, H

Favourites:
ADD

EFFECT OF DRUG SCHEDULING ON THE ANTITUMOR-ACTIVITY AND BONE-MARROW TOXICITY OF TAUROMUSTINE (TCNU)
pp. 403-409(7)
Authors: MATTHEW, AM; CHRISTENSSON, PI; SEIDEGARD, J; TUVESSON, H; BIBBY, MC; HARTLEYASP, B; CREAVEN, PJ

Favourites:
ADD

ELF REGIMEN IN ADVANCED GASTROINTESTINAL MALIGNANCIES - AN ANALYSIS OF ITS CLINICAL EFFECTIVENESS AND TOXICITY
pp. 411-415(5)
Authors: GEBBIA, V; SCIUME, C; CANNATA, G; CURTO, G; VALENZA, R; TESTA, A; CIPOLLA, C; CUSUMANO, A; VERDERAME, F; FORTUNATO, S; DIGESU, G; LEO, P; GEBBIA, N

Favourites:
ADD

CHARACTERIZATION OF THE RELEASE OF DNA BY A HUMAN LEUKEMIA-CELL LINE HL-60
pp. 417-421(5)
Authors: ABOLHASSANI, M; TILLOTSON, JK; CHIAO, JW

Favourites:
ADD

PHORBOL 12-MYRISTATE 13-ACETATE (PMA) INDUCES NEUROENDOCRINE-LIKE DIFFERENTIATION AND REVERSES DOXORUBICIN-RESISTANCE OF HUMAN COLON-CARCINOMA CELLS IN-VITRO
pp. 423-427(5)
Authors: CORREALE, P; CARAGLIA, M; PEPE, S; RICCIARDI, B; BARILE, C; MONTAGNANI, S; PACELLI, R; BIANCO, AR; TAGLIAFERRI, P

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

DIFFERENTIAL EXPRESSION OF E-CADHERIN IN NORMAL, METAPLASTIC AND DYSPLASTIC ESOPHAGEAL MUCOSA - A PUTATIVE BIOMARKER
pp. 441-448(8)
Authors: JANKOWSKI, JA; NEWHAM, PM; KANDEMIR, O; HIRANO, S; TAKEICHI, M; PIGNATELLI, M

Favourites:
ADD

TISSUE CEA AND TPA EXPRESSION IN STAGE-I BREAST-CANCER
pp. 449-452(4)
Authors: GENTA, F; GHIRINGHELLO, B; BOTTA, G; DESANCTIS, C; KATSAROS, D; MANO, MP; SISMONDI, P

Favourites:
ADD

PHENOTYPIC, MOLECULAR AND GENETIC-CHARACTERIZATION OF TRANSFORMED HUMAN BRONCHIAL EPITHELIAL-CELL STRAINS
pp. 461-470(10)
Authors: SCHILLER, JH; SABATINI, L; BITTNER, G; PINKERMAN, CL; MAYOTTE, J; LEVITT, M; MEISNER, L

Favourites:
ADD

ELEVATED PRETREATMENT LEVELS OF SOLUBLE CD8 AND BETA-2-MICROGLOBULIN AS INDICATORS OF RELAPSE IN BREAST-CANCER PATIENTS
pp. 471-474(4)
Authors: KLEIN, B; LEVIN, I; LURIE, H; NYSKA, A; SHAPIRA, J; KRAVITS, M; KLEIN, T

Favourites:
ADD

TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA) MESSENGER-RNA EXPRESSION AND GROWTH-CONTROL IN HUMAN LUNG SQUAMOUS CARCINOMA CELL-LINES
pp. 475-479(5)
Authors: BARTLETT, JMS; RABIASZ, GJ; LANGDON, SP; MILLER, EP; MILLER, WR

Favourites:
ADD

APOPTOSIS AND GROWTH-INHIBITION IN SENSITIVE AND RESISTANT LEUKEMIC-CELLS TREATED WITH ANTICANCER DRUGS
pp. 481-489(9)
Authors: FRANKFURT, OS; SECKINGER, D; SUGARBAKER, EV

Favourites:
ADD

ON THE INTERACTION OF P53 WITH CASEIN KINASE-II
pp. 491-498(8)
Authors: WAGNER, P; APPEL, K; ISSINGER, OG; MONTENARH, M

Favourites:
ADD

RANDOMIZED STUDY COMPARING CHEMOTHERAPY WITH AND WITHOUT ESTROGEN PRIMING IN ADVANCED BREAST-CANCER
pp. 499-501(3)
Authors: HORN, Y; WALACH, N; PAVLOTSKY, A; BARAK, F; BENZ, C

Favourites:
ADD

IMMUNOHISTOCHEMICAL LOCALIZATION OF EPIDERMAL GROWTH-FACTOR AND ITS RECEPTOR IN NORMAL, PREMALIGNANT AND MALIGNANT ORAL-MUCOSA
pp. 503-508(6)
Authors: CHANDRAN, GJ; BALARAM, P; KANNAN, S; PILLAI, MR; NALINAKUMARI, KR; NAIR, MK

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content